Washington, DC – The National Osteoporosis Foundation issued the following statement regarding the impending out-of-pocket cliff threatening the Medicare Part D program: “A looming threat to the Medicare Part D program is set to take effect in 2020 unless Congress takes action. The Part D cliff will significantly increase the catastrophic threshold – the amount… Read more »
News
NOF Named an Official Charity Partner of the TCS New York City Marathon and Fields a Team of Runners Aged 40+ »
The National Osteoporosis Foundation (NOF), the leading bone health organization in the U.S., was named an Official Charity Partner of the 2018 TCS New York City Marathon. The race will take place on Sunday, November 4, 2018. For its inaugural team, NOF has secured five women over the age of 40 to join its Be… Read more »
NOF is Advocating for Increased Medicare Reimbursement for DXA Scans »
Fractures related to osteoporosis threaten the health and independence of older Americans. And fractures are common: more than 2 million fractures happen each year due to osteoporosis. The statistics are staggering and unnecessary. A DXA (Dual-energy X-ray absorptiometry) bone density test is a non-invasive, simple, yet top quality test for screening and diagnosing patients that… Read more »
Leading Organizations Meet To Discuss Unmet Needs In Osteoporosis and Outline An Initial Action Plan »
June 11, 2018| Press Releases On June 11, 2018, leaders from the National Osteoporosis Foundation (NOF), International Osteoporosis Foundation (IOF), and Amgen’s Bone Health and Advocacy Relations teams convened in London, England at the Royal Academy of Medicine. The purpose of the meeting was to develop a concrete plan for a meaningful collaboration between the two organizations. Back row:… Read more »
NOF Statement on New Treatment Option for Glucocorticoid-Induced Osteoporosis (GIOP) »
GIOP is the most common form of secondary osteoporosis. In the U.S., more than 10 percent of patients who receive long-term glucocorticoid treatment are diagnosed with a clinical fracture. The U.S. Food and Drug Administration (FDA) has recently approved the use of denosumab for the treatment of glucocorticoid-induced osteoporosis (GIOP) in men and women at… Read more »
Osteoporosis: Basics to Bone Health Radio Segment »
Listen to this radio segment with NOF Trustee and Bone Health Ambassador, Barbara Hannah Grufferman to get the basics on osteoporosis and bone health, including how to identify your risk factors for osteoporosis and advice you can use to protect your bone health. Listen to the segment now.
Break Free from Osteoporosis for May’s National Osteoporosis Month: What You Need to Know About Your Bone Health at Every Age »
National Osteoporosis Foundation (NOF) Issues Jumping Jack Challenge and Offers New Information and Resources About Bone Health The National Osteoporosis Foundation (NOF) is celebrating May’s National Osteoporosis Month with a variety of activities and resources to help people of all ages understand the importance of good bone health. NOF’s call to action to Break Free… Read more »
NOF’s Bone Health Ambassador, Barbara Hannah Grufferman, Featured on Live with Kelly and Ryan »
Watch NOF’s Bone Health Ambassador, Barbara Hannah Grufferman, on Live with Kelly and Ryan. She shares tips for aging gracefully and her number one tip is to protect your bones by exercising, getting plenty of calcium and vitamin D, and making sure you ask your doctor if you need a bone density test. View the… Read more »
NOF Announces Dr. Joan Lappe as the 2018 Recipient of the Lawrence G. Raisz Memorial Lecture Award »
The National Osteoporosis Foundation (NOF) announces Joan Lappe, Ph.D., RN, FAAN, Criss/Beirne Professor of Nursing and Associate Dean for Research and Professor of Medicine, Osteoporosis Research Center, Creighton University and NOF Trustee, as the recipient of its 2018 Lawrence G. Raisz, MD Memorial Lecture Award. Dr. Lappe will present highlights from her research on nutrition… Read more »
NOF Statement on Medicare Part D »
Washington, DC – The National Osteoporosis Foundation (NOF) sent the following statement to Members of Congress on the importance of protecting Medicare Part D: NOF is concerned that recent changes to the Medicare Part D program in the Bipartisan Budget Act (BBA) of 2018 opens the door to other potentially harmful changes that could disrupt… Read more »